Gutstein, David E.
4 papers on CoChatORCID 0000-0001-7776-3477
Most cited papers
- Verified
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering
Cited by 1,801
- Verified
Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein, D. (1999) · Cardiovascular Research
Coronary Interventions and DiagnosticsAtherosclerosis and Cardiovascular Diseases
Cited by 151
- Verified
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
Thomas, T., Zhou, H., Karmally, W., Ramakrishnan, R., Holleran, S., Liu, Y., Jumes, P., Wagner, J. A., Hubbard, B., Previs, S. F., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 96
- Verified
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension
Boucherat, O., Yokokawa, T., Krishna, V., Kalyana-Sundaram, S., Martineau, S., Breuils-Bonnet, S., Azhar, N., Bonilla, F., Gutstein, D., Potus, F., et al. (2022) · Nature Cardiovascular Research
Pulmonary Hypertension Research and TreatmentsCardiac Fibrosis and Remodeling
Cited by 64
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free